DLA Piper advises Gener8 in its acquisition by Sverica Capital Management

DLA Piper represented Gener8, LLC, a designer and manufacturer of life science instrumentations and medical devices headquartered in Sunnyvale, California, in its acquisition by private equity firm Sverica Capital Management LP.

Gener8 designs and manufactures life science instrumentation, complex clinical devices and advanced industrial systems, leveraging expertise in microfluidics, optics, electronics and embedded systems. Its capabilities include end-to-end design, development, prototype and low-to-medium volume manufacturing.

The DLA Piper team was led by partner Curtis Mo (Silicon Valley) and included partners Jeffrey Aronson, SeoJung Park and William Hoffman (all of Silicon Valley), Jeffrey Salinger (New York), Thomas deButts, James Czaban and Jeffrey Hare (all of Washington, DC), Mark Boxer and Margaret Keane (both of San Francisco), and Brad Jorgensen (Austin); and associates Evan Youngstrom, Syeda Nawroj and Eduardo Blanco (all of Silicon Valley), Thomas Reynolds (Washington, DC), Nika Antonikova (San Diego), Nelson Lam (San Francisco), and Jae Kim (Philadelphia).